Planta Med 2007; 73(4): 363-365
DOI: 10.1055/s-2007-967128
Letter
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Two Major Urinary Metabolites of Scutellarin in Rats

Feng Qiu1 , HongJun Xia1 , TieYing Zhang1 , Xin Di2 , GeXia Qu1 , XinSheng Yao1
  • 1Department of Natural Products Chemistry, Shenyang Pharmaceutical University, Shenyang, Liaoning, P. R. China
  • 2Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, Shenyang, Liaoning, P. R. China
Further Information

Publication History

Received: May 9, 2006

Accepted: January 29, 2007

Publication Date:
12 March 2007 (online)

Abstract

Urinary metabolites of scutellarin, the main effective constituent of breviscapine, a cerebrovascular and cardiovascular drug consisting of total flavonoids of Erigeron breviscapus, were investigated in rats. Two major metabolites were isolated from the urine of rats following oral administration of scutellarin and identified as scutellarein 6,7-di-O-β-D-glucuronide (M1) and scutellarein (M2), respectively, on the basis of chemical and spectroscopic evidence. M1 was reported as a metabolite of scutellarin for the first time.

References

  • 1 Wei N. Advances of breviscapine in clinical applications and its side-effects.  China Pharmacist. 2001;  4 144-6.
  • 2 He W, Zeng F. Effect of breviscapine on ischemic cerebrovascular disease and its clinical investigation.  Chin J Clin Pharmacol. 2002;  18 458-61.
  • 3 Hao X, Cheng G, Yu J, He Y, An F, Sun J. et al . Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats.  Pharmazie. 2005;  60 477-8.
  • 4 Huang J, Weng W, Huang X, Ji Y, Chen E. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.  Eur J Drug Metab. 2005;  30 165-70.
  • 5 Huang J, Li N, Yu Y, Weng W, Huang X. Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC.  J Pharmaceut Biomed. 2006;  40 465-71.
  • 6 Li N, Huang J, Weng W, Huang Z, Cai J, Yu Y. Determination of scutellarin in rabbit plasma after oral administration by HPLC-MS with solid-phase extraction.  J Chin Pharm Sci. 2005;  14 38-42.
  • 7 Zhang J, Che Q, Li S, Zhou T. Study on metabolism of scutellarin in rats by HPLC-MS and HPLC-NMR.  J Asian Nat Prod Res. 2003;  5 249-56.
  • 8 Hattori M, Huang X, Che Q, Kawata Y, Tezuka Y, Kikuchi T. et al . 6-Hydroxykaempferol and its glycosides from Carthamus tinctorius petals.  Phytochemistry. 1992;  31 4001-4.
  • 9 Nakazawa T, Ohsawa K. Metabolites of orally administered Perilla frutescens extract in rats and humans.  Biol Pharm Bull. 2000;  23 122-7.
  • 10 Li L, Liu D, Jiang J, Hu B. The development of pharmacological studies on scutellarin.  Zhongcaoyao. 2006;  37 9-11.

Prof. Feng Qiu

Department of Natural Products Chemistry

Shenyang Pharmaceutical University

No.103 Wenhua road

Shenyang

110016 Liaoning

People’s Republic of China

Phone: +86-24-2398-6463

Fax: +86-24-2399-3994

Email: fengqiu2000@tom.com

>